Advances in cardiovascular pharmacological therapy.
Progress in the pharmacological management of cardiovascular disease has been accompanied by the appearance of drugs with never before seen capabilities to alter human physiological processes. The widespread use of these potent agents poses a challenge to the oral and maxillofacial surgeon attempting to safely manage patients in the ambulatory setting. This article reviews the field of contemporary cardiovascular pharmacotherapy from the aspect of how it affects the practice of oral and maxillofacial surgery.
Hupp
J R
JR
Department of Oral/Maxillofacial Surgery, University of Medicine and Dentistry of New Jersey, Newark.
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D006801:Humans; D013515:Surgery, Oral; D013565:Sympatholytics / Q000145:classification / Q000627:therapeutic use*
D000889:Anti-Arrhythmia Agents; D002121:Calcium Channel Blockers; D013565:Sympatholytics